Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 7Leukemia, Myeloid, Acute 5Neuroblastoma 2Neoplasm Metastasis 2Thyroid Neoplasms 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Fibrolamellar hepatocellular carcinoma 1

Interventions

Vincristine 8X-Rays 6Temozolomide 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cyclophosphamide 6Specimen Handling 5Irinotecan 5Nuclear Medicine Department, Hospital 4Biopsy 4Radiotherapy 3Radiation 3Dactinomycin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine 2ensartinib 2Vinorelbine 2Proton Therapy 2LY3023414 2Ifosfamide 2Filgrastim 2Etoposide 2Doxorubicin 2Dexrazoxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Sorafenib × 90 days × Clear all
NCT01871766 2026-04-24

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
115 enrolled
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡